4,4’-((4,4’-Diamino-[1,1’-Biphenyl]-3,3’-Diyl)Bis(Oxy))Dibutyric Acid Dihydrochloride 4,4’-((4,4’-二氨基-[1,1’-联苯]-3,3’-二基)双(氧基))二丁酸二盐酸盐
CAS 56455-90-4 MFCD00236955
化学结构图
SMILES: Cl.Cl.NC1C=CC(=CC=1OCCCC(O)=O)C1C=C(OCCCC(O)=O)C(N)=CC=1
化学属性
| Mol. Formula | C20H24N2O6· 2HCl |
|---|---|
| Mol. Weight | 461.34 |
别名和识别编码
| Chemical Name | 4,4’-((4,4’-Diamino-[1,1’-Biphenyl]-3,3’-Diyl)Bis(Oxy))Dibutyric Acid Dihydrochloride |
|---|---|
| Synonym | γ,γ'-(4,4'-Diamino-3,3'-biphenylylenedioxy)dibutyric acid Butyric acid, 4,4'-(4,4'-diamino-m,m'-biphenylenedioxy)di-, gamma,gamma'-3,3'-Benzidine dioxydibutyric acid dihydrochloride Dicarboxidine dihydrochloride |
| MDL Number | MFCD00236955 |
| PubChem Substance ID | 24893982 |
| Wiswesser Line Notation | QV3OR BZ ER DZ CO3VQ &GH 2 |
| CAS Number | 56455-90-4 |
| Chemical Name Translation | 4,4’-((4,4’-二氨基-[1,1’-联苯]-3,3’-二基)双(氧基))二丁酸二盐酸盐 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Biochemicals and Reagents, Enzyme Substrates, Enzymes, Inhibitors, and Substrates, Peroxidase Substrates, Substrates by Enzyme
安全信息
GHS Symbol
- P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
- P305+P351+P338
- H315 Causes skin irritation 会刺激皮肤
- H319 Causes serious eye irritation 严重刺激眼睛
- H335 May cause respiratory irritation 可能导致呼吸道刺激
- S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后，立即用大量水冲洗并征求医生意见；
- S36 Wear suitable protective clothing 穿戴适当的防护服；
- S22 Do not breathe dust 不要吸入粉尘；
- R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 21250 mg/kg/2Y-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application REFERENCE : JJIND8 JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For publisher information, see JNCIEQ. Volume(issue)/page/year: 62,301,1979
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 23400 mg/kg/2Y-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors Tumorigenic - tumors at site of application REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 29,187,1979
TYPE OF TEST : TD - Toxic dose (other than lowest) ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 37500 mg/kg/2Y-I TOXIC EFFECTS : Tumorigenic - equivocal tumorigenic agent by RTECS criteria Tumorigenic - tumors at site of application REFERENCE : VOONAW Voprosy Onkologii. Problems of Oncology. For English translation, see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.1-10, 1928-37; V.1- 1955- Volume(issue)/page/year: 25(7),43,1979
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >600 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 29,187,1979
TYPE OF TEST : LDLo - Lowest published lethal dose ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >1200 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 29,187,1979
京ICP备2020036287号